Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000,000
- 试验地点
- 1
研究概览
简要总结
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
详细描述
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis. Using patient-completed questionnaires, combined with outpatient visit records and telephone follow-up, this study will explore the following aspects:
Assess the incidence and severity of cancer-related fatigue in patients with malignant tumors.
Analyze the influencing factors of cancer-related fatigue, including tumor type, treatment regimen, disease stage, efficacy of anti-tumor therapy, adverse events associated with anti-tumor therapy, and concomitant medications.
Evaluate the impact of cancer-related fatigue on anti-tumor treatment and prognosis.
Assess the multidimensional state and severity of cancer-related fatigue in patients with malignant tumors using the Brief Fatigue Inventory - Cancer (BFI-C) and the Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female, aged 18 years or older.
- •Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
- •Malignant tumor confirmed histologically or cytologically.
排除标准
- •Pregnant or breastfeeding women.
- •Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
- •Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
- •Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
- •Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
- •Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.